MettlerToledo
0K10.L
$1 368.65 -3.65%
Exchange: LSE | Sector: Healthcare | Industry: Medical Pharmaceuticals
Q2 2025
Published: Aug 1, 2025

Earnings Highlights

  • Revenue of $983.22M up 3.9% year-over-year
  • EPS of $9.77 decreased by 6.2% from previous year
  • Gross margin of 57.2%
  • Net income of 202.35M
  • "N/A" - N/A
0K10.L
Company 0K10.L

Executive Summary

Mettler-Toledo International Inc. (0K10.L) delivered a sound QQ2 2025 with revenue of USD 983.2 million, a gross margin of 57.2%, and net income of USD 202.3 million. Year-over-year revenue grew 3.9%, while sequential (quarter-over-quarter) revenue rose 11.3% on the back of continued demand for precision instruments across its five geographic segments. At the operating level, margins remained robust (operating margin ~27.0%) and EBITDA stood at USD 295.9 million, underscoring the business’s high-value, high-margin profile and strong cash generation.

Key Performance Indicators

Revenue
Increasing
983.22M
QoQ: 11.26% | YoY: 3.85%
Gross Profit
Increasing
562.30M
57.19% margin
QoQ: 10.54% | YoY: 2.70%
Operating Income
Decreasing
265.71M
QoQ: 21.03% | YoY: -0.08%
Net Income
Decreasing
202.35M
QoQ: 23.69% | YoY: -8.78%
EPS
Decreasing
9.77
QoQ: 24.62% | YoY: -6.24%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q3 2025 1,029.70 10.57 +7.9% View
Q2 2025 983.22 9.77 +3.9% View
Q1 2025 883.74 7.84 -4.6% View
Q4 2024 1,045.13 11.96 +11.8% View
Q3 2024 954.54 9.94 +1.3% View